tivoxavir marboxil (TRX100) / Traws Pharma - LARVOL DELTA

A Randomized, Double-Blind, Placebo-Controlled, Phase 1, Dose Escalation (with optional food effect) Study of Orally Administered TRX-100 to Evaluate the Safety, Tolerability and Pharmacokinetics of Single Ascending Doses of TRX-100 in Healthy Volunteers (ANZCTR) - P1 | N=40 | Completed | Sponsor: Trawsfynydd Therapeutics AU Pty Ltd (on behalf of Traws Pharma, Inc.) | Recruiting ➔ Completed

Trial completion • Infectious Disease • Influenza • Respiratory Diseases

A Clinical Study Aiming to Assess Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of TRX-100 in Healthy Volunteers (clinicaltrials.gov) - P1 | N=32 | Recruiting | Sponsor: Traws Pharma, Inc.

New P1 trial

A Randomized, Double-Blind, Placebo-Controlled, Phase 1, Dose Escalation (with optional food effect) Study of Orally Administered TRX-100 to Evaluate the Safety, Tolerability and Pharmacokinetics of Single Ascending Doses of TRX-100 in Healthy Volunteers (ANZCTR) - P1 | N=40 | Recruiting | Sponsor: Trawsfynydd Therapeutics AU Pty Ltd (on behalf of Traws Pharma, Inc.) | Not yet recruiting ➔ Recruiting | Initiation date: Aug 2024

Enrollment open • Trial initiation date • Infectious Disease • Influenza • Respiratory Diseases